All Pharma News
Biogen lays off 100-plus Reata staffers

Biogen lays off 100-plus Reata staffers
Fraiser Kansteiner FIERCE PHARMA
12 Oct 2023
Share Share
Reata Pharmaceuticals Stockholders Approve Merger Transaction With Biogen Inc.

Reata Pharmaceuticals Stockholders Approve Merger Transaction With Biogen Inc.
BUSINESSWIRE
21 Sep 2023
Share Share
How Biogen courted Reata for $7.3B—and outbid a competitor

How Biogen courted Reata for $7.3B—and outbid a competitor
Eric Sagonowsky FIERCE PHARMA
15 Aug 2023
Share Share
Biogen to buy Reata for $6.5 bln to bulk up rare disease portfolio

Biogen to buy Reata for $6.5 bln to bulk up rare disease portfolio
HEALTH ET
29 Jul 2023
Share Share
Biogen to Acquire Reata Pharmaceuticals

Biogen to Acquire Reata Pharmaceuticals
GLOBENEWSWIRE
28 Jul 2023
Share Share
Plano-based Reata Pharmaceuticals launches its first drug, Skyclarys

Plano-based Reata Pharmaceuticals launches its first drug, Skyclarys
DALLASNEWS
29 Jun 2023
Share Share
Reata Pharma Announces Approval of Prior Approval Supplement for SKYCLARY

Reata Pharma Announces Approval of Prior Approval Supplement for SKYCLARY
BUSINESSWIRE
27 Jun 2023
Share Share
Reata Pharmaceuticals Announces FDA Filing Acceptance of SKYCLARYS®

Reata Pharmaceuticals Announces FDA Filing Acceptance of SKYCLARYS®
BUSINESSWIRE
15 Jun 2023
Share Share
Reata Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President

Reata Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President
BUSINESSWIRE
13 Jun 2023
Share Share
Reata Announces Participation in the Goldman Sachs 44th Healthcare Conference

Reata Announces Participation in the Goldman Sachs 44th Healthcare Conference
BUSINESSWIRE
06 Jun 2023
Share Share